Question thread · 2 questions
Whether it will provide an update on current considerations regarding advice to NHS boards on the routine use of sapropterin in NHS Scotland.
Started with S6W-07156 on 2 Mar 2022; latest 16 May 2022. Each later question says it follows up an earlier answer.
Follow-ups
1
Span
75 days
Answered
2 of 2
Asked by
1
The thread, in order
Each answer’s opening lines; open a question for the full text-
To ask the Scottish Government whether it will provide an update on current considerations regarding advice to NHS boards on the routine use of sapropterin in NHS Scotland.
Humza Yousaf, 28 Mar 2022: The first generic version of sapropterin has recently received a Marketing Authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA). Healthcare Improvement Scotland are working to provide updated advice to Boards to enable routine prescribing of Sapropterin. We expect this to be in place in Ap… -
Whether it will provide a further update on advice provided to NHS boards to enable the routine prescribing of sapropterin for people with phenylketonuria (PKU).
Humza Yousaf, 26 May 2022: Healthcare Improvement Scotland is working to provide updated advice to NHS Boards to enable routine prescribing of sapropterin. We now expect this to be in place in June. In the meantime, doctors can request access to medicines that are not generally available on the NHS on an individual case-by-case basis through lo…
How this thread is put together
- Follow-up
- A question whose text says it is “further to the answer to question …” (or reply, response, or asks for a “substantive answer” to an earlier question). The question it names is its parent.
- Several citations
- When a question cites more than one earlier question, the most recent one we hold is used as the parent; the others are listed as “also cites”.
- Thread
- Follow parents back to the first question; every question that leads back to it is in this thread. Branches are shown in date order.